
The Mesothelioma Center News – Page 14
-
Veterans & MilitaryThe U.S. Department of Veterans Affairs has increased its monthly payments to disabled veterans by 8.7%, the largest annual increase in 40 years. Veterans…
-
Legislation & Litigation
Honeywell to Fund Asbestos Trust With $1.3 Billion
To eliminate future funding obligations, Honeywell International Inc. has agreed to a one-time, lump sum payment of $1.325 billion to the asbestos trust… -
Research & Clinical Trials
Looking Beyond Clinical Trials for Mesothelioma Treatment
Clinical trial results should not always be the guiding force when a mesothelioma cancer patient and their medical team determine what therapy path… -
Research & Clinical Trials
Global Mesothelioma Cases Nearly Double Over 30 Years
The number of people in the world diagnosed annually with mesothelioma cancer has almost doubled in the last 30 years, accentuating the need… -
Research & Clinical Trials
Latest Study Compares Major Pleural Mesothelioma Surgeries
Mesothelioma patients may benefit more from aggressive extrapleural pneumonectomy surgery than from the lung-sparing pleurectomy and decortication currently being recommended as an alternative by… -
Asbestos Exposure & Bans
Congress Resumes Asbestos Ban Efforts After ProPublica Report
U.S. lawmakers and public health advocates have renewed their call for Congress to pass a long-awaited legislative ban of asbestos, sparked by the… -
Research & Clinical Trials
New Research Focuses on Mesothelioma Brain Metastasis
Distant metastasis is common with malignant pleural mesothelioma – more than 60% of patients experience it – but rarely is it found around… -
Research & Clinical Trials
Latest Mesothelioma T-Cell Clinical Trial Moves to Phase II
The most recent T-cell therapy aimed at mesothelioma cancer has advanced to phase II of the clinical trial process, with researchers exploring its… -
Research & Clinical Trials
Study: Cancer Enzyme Slows Growth of Pleural Mesothelioma
Patients with pleural mesothelioma may extend their survival by an estimated 30% when the latest anti-cancer enzyme is added to standard chemotherapy, according… -
Research & Clinical Trials
Orphan Drug Designation Given to New Mesothelioma CAR T-Cell Therapy
In early 2023, the world-class Hospital of the University of Pennsylvania will open a groundbreaking clinical trial for mesothelioma patients utilizing a next-generation…